3D Systems 경영진
경영진 기준 점검 4/4
3D Systems CEO는 Jeff Graves, May2020 에 임명되었습니다 의 임기는 6.33 년입니다. 총 연간 보상은 $1.49M, 57.1% 급여 및 42.9% 보너스(회사 주식 및 옵션 포함)로 구성됩니다. 는 $3.60M 가치에 해당하는 회사 주식의 0.98% 직접 소유합니다. 경영진과 이사회의 평균 재임 기간은 3.4 년과 6.8 년입니다.
핵심 정보
Jeff Graves
최고경영자
US$1.5m
총 보수
| CEO 급여 비율 | 57.11% |
| CEO 재임 기간 | 6yrs |
| CEO 지분 보유율 | 1.0% |
| 경영진 평균 재임 기간 | 3.4yrs |
| 이사회 평균 재임 기간 | 6.8yrs |
최근 경영진 업데이트
Recent updates
내러티브 업데이트 • May 06
DDD: Dental Solutions And Factory Software Will Support Future Earnings Power
Analysts have slightly lowered their price target on 3D Systems to $5.00, citing modest adjustments to the discount rate, revenue growth, profit margin expectations, and assumed future P/E. Together, these factors point to a more cautious but still constructive view on the stock's valuation.Seeking Alpha • Apr 22
3D Systems: Aerospace And Defense Narrative Isn't Compelling
Summary 3D Systems faces persistent headwinds from dental market weakness and soft capital spending, although this is now being offset by strength in aerospace, defense, and personalized healthcare. DDD expects solid aerospace and defense revenue growth in 2026, but this appears insufficient to create a topline growth acceleration. Cost-cutting efforts are paying off, leading to improved margins, but 3D Systems remains a long way from GAAP profitability. While 3D Systems' valuation is modest, this reflects the company's weak fundamentals rather than mispricing. Read the full article on Seeking Alpha내러티브 업데이트 • Apr 22
DDD: New CFO And Industrial Expansion Will Support Future Earnings Power
Analysts have made a slight adjustment to their price target on 3D Systems, reflecting updated assumptions about the discount rate, revenue growth, profit margins, and future P/E. This has led to a modest recalibration of fair value, with their target remaining close to $5.00 per share.내러티브 업데이트 • Apr 07
DDD: New CFO And Dental Expansion Will Support Future Earnings Power
Analysts have maintained their price target for 3D Systems at $5.00, reflecting only minor adjustments to assumptions related to discount rate, revenue growth, profit margin, and future P/E, which together support an unchanged valuation view. What's in the News Phyllis Nordstrom is set to become Chief Financial Officer on March 23, 2026, after serving as Interim CFO since August 2025, while continuing as Chief Administrative Officer reporting to President and CEO Dr. Jeffrey Graves (Key Developments).내러티브 업데이트 • Mar 24
DDD: Dental Solutions Expansion And New CFO Will Support Future Earnings Power
Analysts now set a higher price target of $5.00 for 3D Systems, up from $4.75, citing updated assumptions for revenue growth, profit margins, a lower discount rate, and a higher future P/E multiple. What's in the News Phyllis Nordstrom is appointed Chief Financial Officer, effective March 23, 2026, after serving as Interim CFO since August 2025.
내러티브 업데이트 • Mar 09
DDD: Expanded Med Tech Indications And Digital Dentures Will Support Margin Upside
Analysts have slightly trimmed their price target on 3D Systems to $3.63, reflecting small tweaks to assumptions around discount rate, profit margin and future P/E, while keeping their fair value view broadly in line. What's in the News 3D Systems introduced three new NextDentJet Base shades for its NextDent Jetted Denture Solution, adding Dark Pink, Light Pink, and Red Pink to the existing Light Tone option to better match a range of natural gum tones.내러티브 업데이트 • Feb 22
DDD: Expanded Dental And Orthopedic Applications Will Support Higher Margin Confidence
Analysts have maintained their $3.63 fair value estimate for 3D Systems, with only minor adjustments to inputs, including a slightly higher discount rate and modestly lower profit margin assumptions, shaping this latest price target update. What's in the News 3D Systems introduced three new NextDentJet Base shades: Dark Pink, Light Pink, and Red Pink, expanding its NextDent Jetted Denture Solution to four base shades aimed at better matching a wider range of natural gum tones across patient populations.내러티브 업데이트 • Feb 08
DDD: Expanded Med Tech Indications Will Support Higher Margin Confidence
Analysts have adjusted their price targets on 3D Systems slightly, with modest tweaks to the discount rate, profit margin expectations, and forward P/E assumptions, leading to a refined view of fair value for the shares. What's in the News FDA granted 510(k) clearance expanding indications for 3D Systems' VSP Orthopedics platform to include skeletally mature adolescents of normal bone stature, moving prior off label use for these patients into standard, reimbursable procedures at leading centers (Key Developments).내러티브 업데이트 • Jan 24
DDD: Margin Execution And Med Tech Expansion Will Support Higher Confidence
Analysts have raised their price target on 3D Systems to US$4.75 from US$4.00. This reflects updated views on the company's margin outlook and valuation multiples.내러티브 업데이트 • Jan 10
DDD: Expanded Med Tech Margins And Execution Will Support Greater Market Confidence
Analysts lifted their price target on 3D Systems to $4.75 from $4.00, reflecting updated assumptions around discount rates, profit margins and future P/E multiples that influence their valuation outlook. Analyst Commentary Recent research reflects a modestly more constructive stance on 3D Systems, with the updated US$4.75 price target framing how some on the Street view the balance of risk and reward.분석 기사 • Jan 09
There's No Escaping 3D Systems Corporation's (NYSE:DDD) Muted Revenues Despite A 45% Share Price Rise
3D Systems Corporation ( NYSE:DDD ) shareholders are no doubt pleased to see that the share price has bounced 45% in...내러티브 업데이트 • Dec 26
DDD: Med Tech And Industrial Demand Will Drive Improved Earnings Power
Analysts have raised their price target on 3D Systems to $4.75 from $4.00, reflecting improved expectations for a return to revenue growth and a slightly higher assumed future earnings multiple, despite a modestly higher discount rate. Analyst Commentary Bullish analysts highlight that the new price target reflects growing confidence in 3D Systems’ ability to stabilize its core business and return to sustainable top line expansion.내러티브 업데이트 • Dec 12
DDD: Execution On New Products And Cost Discipline Will Drive Confidence
Analysts have modestly increased their price target for 3D Systems to $4.75 from $4.00, citing a slightly higher assumed future earnings multiple and a marginally higher discount rate while leaving long term growth and margin expectations effectively unchanged. Analyst Commentary Analysts view the modest price target increase as a reflection of slightly improved confidence in 3D Systems' ability to execute on its strategy, while still recognizing meaningful execution and market risks at current levels.내러티브 업데이트 • Nov 27
DDD: Margin Stability And Cost Discipline Will Drive Confidence In 2025
Analysts have raised their price target on 3D Systems from $4.00 to $4.75, citing shifts in projected discount rates and modest adjustments to revenue growth expectations as core reasons for their updated outlook. Analyst Commentary Analyst sentiment on 3D Systems has shifted following recent developments, prompting a closer examination of both the company’s growth potential and the associated risks.분석 기사 • Nov 12
3D Systems' (NYSE:DDD) Profits Appear To Have Quality Issues
The stock price didn't jump after 3D Systems Corporation ( NYSE:DDD ) posted decent earnings last week. We did some...내러티브 업데이트 • Nov 09
DDD: Margin Strength And New Contract Will Drive Outperformance Ahead
Analysts have increased their price target for 3D Systems from $3.25 to $3.63. They cite improved revenue growth and a significant strengthening of profit margins as key factors driving the outlook higher.분석 기사 • Nov 08
Benign Growth For 3D Systems Corporation (NYSE:DDD) Underpins Stock's 31% Plummet
The 3D Systems Corporation ( NYSE:DDD ) share price has softened a substantial 31% over the previous 30 days, handing...분석 기사 • Sep 24
3D Systems Corporation (NYSE:DDD) Shares Fly 34% But Investors Aren't Buying For Growth
Despite an already strong run, 3D Systems Corporation ( NYSE:DDD ) shares have been powering on, with a gain of 34% in...내러티브 업데이트 • Aug 15
Healthcare Customization And Additive Manufacturing Will Forge A Resilient Future
As 3D Systems’ net profit margin and revenue growth forecasts remain unchanged at 0.72% and -4.5% respectively, the analyst consensus price target is also maintained at $3.25. What's in the News 3D Systems launched the NextDent Jetted Denture Solution and NextDent 300 MultiJet printer in the U.S., enabling rapid, post-cure-free, single-piece, dual-material dentures with improved aesthetics and durability.Seeking Alpha • Apr 14
3D Systems: Restructuring And The Challenging Path To Turnaround
Summary 3D Systems face revenue decline and margin pressures due to manufacturing sector weakness and high-interest rates, leading to a -10.5% revenue CAGR from FY21 to FY24. Management's restructuring plan includes a $50 million cost-cutting program and the sale of Geomagic software, but breakeven requires significant revenue growth and an industry rebound. Comparison with Stratasys and Nano Dimension shows 3D Systems' underperformance in revenue, margins, and debt, with a steep stock price decline of 86.42% since January 2022. Despite restructuring efforts, high competition and past acquisition strategy raise doubts about achieving profitability, leading to a "hold" rating for 3D Systems. Read the full article on Seeking Alpha
새 내러티브 • Mar 29
Regenerative Medicine And Dental Focus Will Open New Markets
Collaborations in regenerative medicine and dental market focus position 3D Systems for potential future revenue growth.분석 기사 • Feb 13
A Piece Of The Puzzle Missing From 3D Systems Corporation's (NYSE:DDD) 39% Share Price Climb
Despite an already strong run, 3D Systems Corporation ( NYSE:DDD ) shares have been powering on, with a gain of 39% in...Seeking Alpha • Jan 31
3D Systems: A Strong One For Speculative Investors
Summary 3D Systems is a leader in 3D printing with diverse technologies, excelling in medical, aerospace, and automotive sectors, despite financial challenges. The company is investing in bioprinting and custom implants, with valuable partnerships in defense and aerospace, driving future growth. Revenue is expected to decline in 2024 due to macroeconomic conditions, but operational efficiency and new product launches show promise. Investors with high-risk tolerance may consider 3D Systems for speculative growth, while conservative investors should wait for stable profitability. Read the full article on Seeking AlphaSeeking Alpha • Nov 18
3D Systems: Waiting For More Clarity On The Profitability Path
Summary 3D Systems is a world leader in 3D printing and offers a complete portfolio of metal and plastic materials. It enjoys a solid positioning in the healthcare segment (dental, prosthesis, and regenerative medicine). As the sector makes losses and consolidates, the firm could reinforce its positioning. The balance sheet is tight, and a clear path toward profitability remains to be determined. While the stock is undervalued, a rerating seems unlikely unless I can refinance its 2026 obligation or become rapidly cash flow positive. I rate the stock as a HOLD. Read the full article on Seeking AlphaSeeking Alpha • Aug 30
3D Systems: Green Shoots Amidst Ongoing Macro Challenges
Summary 3D Systems reported weak results in Q1 but returned to sequential growth in the second quarter and now appears to be more optimistic about its near-term prospects. 3D Systems expects to be profitable on an adjusted EBITDA basis in the fourth quarter on the back of revenue growth and cost-cutting efforts. 3D Systems' valuation is now fairly modest, which could result in solid returns if the company can meet its guidance. Industry dynamics remain tough, though, and I continue to think that there are better ways to capitalize on additive manufacturing than hardware companies. Read the full article on Seeking AlphaSeeking Alpha • May 30
3D Systems: Don't Print Your Hopes Up At The 52-Week Low
Summary 3D Systems Corp has faced a challenging industry backdrop with declining sales for key additive manufacturing markets. The company has yet to file its 2023 annual report. We expect shares to remain under pressure. Read the full article on Seeking Alpha분석 기사 • Mar 01
Analyst Estimates: Here's What Brokers Think Of 3D Systems Corporation (NYSE:DDD) After Its Yearly Report
3D Systems Corporation ( NYSE:DDD ) missed earnings with its latest yearly results, disappointing overly-optimistic...Seeking Alpha • Feb 29
3D Systems: Another Difficult Year Ahead
Summary 3D Systems reported soft Q4 2023 results, with printer sales and dental orthodontics areas of particular weakness. Competition from China and customer concentration in the dental business pose challenges for 3D Systems. The company is implementing cost-cutting initiatives and focusing on regenerative medicine to stem losses and drive growth. DDD's valuation remains relatively high given the challenges facing the company and its lack of differentiation. Read the full article on Seeking AlphaCEO 보수 분석
| 날짜 | 총 보수 | 급여 | 회사 수익 |
|---|---|---|---|
| Dec 31 2025 | US$1m | US$850k | US$30m |
| Sep 30 2025 | n/a | n/a | US$16m |
| Jun 30 2025 | n/a | n/a | -US$145m |
| Mar 31 2025 | n/a | n/a | -US$277m |
| Dec 31 2024 | US$2m | US$850k | -US$256m |
| Sep 30 2024 | n/a | n/a | -US$515m |
| Jun 30 2024 | n/a | n/a | -US$348m |
| Mar 31 2024 | n/a | n/a | -US$350m |
| Dec 31 2023 | US$7m | US$850k | -US$363m |
| Sep 30 2023 | n/a | n/a | -US$96m |
| Jun 30 2023 | n/a | n/a | -US$122m |
| Mar 31 2023 | n/a | n/a | -US$126m |
| Dec 31 2022 | US$6m | US$850k | -US$123m |
| Sep 30 2022 | n/a | n/a | -US$104m |
| Jun 30 2022 | n/a | n/a | US$227m |
| Mar 31 2022 | n/a | n/a | US$250m |
| Dec 31 2021 | US$9m | US$837k | US$322m |
| Sep 30 2021 | n/a | n/a | US$308m |
| Jun 30 2021 | n/a | n/a | -US$57m |
| Mar 31 2021 | n/a | n/a | -US$85m |
| Dec 31 2020 | US$6m | US$489k | -US$150m |
보상 대 시장: Jeff의 총 보수(USD1.49M)는 US 시장에서 비슷한 규모 기업의 평균(USD2.52M)보다 낮습니다.
보상과 수익: Jeff의 보상은 지난 1년 동안 회사 실적과 일치했습니다.
CEO
Jeff Graves (64 yo)
6yrs
재임 기간
US$1,487,950
보수
Dr. Jeffrey Alan Graves, also known as Jeff, Ph D., is Director of Integra LifeSciences Corporation. He is Independent Director of Integra LifeSciences Holdings Corporation from December 12, 2023.Dr. Grav...
리더십 팀
| 이름 | 직위 | 재임 기간 | 보수 | 지분 |
|---|---|---|---|---|
| President | 6yrs | US$1.49m | 0.98% $ 3.6m | |
| Co-Founder | no data | US$527.51k | 0.36% $ 1.3m | |
| Executive VP | 3.3yrs | US$1.65m | 0.54% $ 2.0m | |
| Executive Vice President of Engineering & Operations | 3.4yrs | US$638.97k | 0.19% $ 700.7k | |
| Executive VP of Additive Solutions & Chief Commercial Officer | 5.8yrs | US$830.05k | 0.34% $ 1.3m | |
| Senior VP of General Counsel & Corporate Secretary | 1.9yrs | 데이터 없음 | 0.098% $ 359.8k |
3.4yrs
평균 재임 기간
58yo
평균 나이
경험이 풍부한 관리: DDD의 경영진은 경험이 있음으로 간주됩니다(평균 재임 3.4 년).
이사회 구성원
| 이름 | 직위 | 재임 기간 | 보수 | 지분 |
|---|---|---|---|---|
| President | 6.3yrs | US$1.49m | 0.98% $ 3.6m | |
| Co-Founder | 4yrs | US$527.51k | 0.36% $ 1.3m | |
| Independent Director | 30.3yrs | US$203.49k | 0.35% $ 1.3m | |
| Member of Medical Advisory Board | 3.9yrs | 데이터 없음 | 데이터 없음 | |
| Independent Director | 10.5yrs | US$218.49k | 0.24% $ 880.6k | |
| Independent Director | 26.6yrs | US$233.49k | 0.19% $ 684.7k | |
| Independent Chairman of the Board | 9.2yrs | US$388.49k | 0.12% $ 458.9k | |
| Independent Director | 8.9yrs | US$233.49k | 0.12% $ 455.4k | |
| Chair of Medical Advisory Board | 4yrs | 데이터 없음 | 데이터 없음 | |
| Independent Director | 7.2yrs | US$218.49k | 0.11% $ 390.4k | |
| Independent Director | 5.4yrs | US$218.49k | 0.10% $ 370.9k | |
| Independent Director | 4.4yrs | US$247.73k | 0.088% $ 324.2k |
6.8yrs
평균 재임 기간
70.5yo
평균 나이
경험이 풍부한 이사회: DDD의 이사회는 경험이 있음으로 간주됩니다(평균 재임 6.8 년).
기업 분석 및 재무 데이터 상태
| 데이터 | 최종 업데이트 (UTC 시간) |
|---|---|
| 기업 분석 | 2026/05/07 10:11 |
| 종가 | 2026/05/07 00:00 |
| 수익 | 2025/12/31 |
| 연간 수익 | 2025/12/31 |
데이터 소스
당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.
| 패키지 | 데이터 | 기간 | 미국 소스 예시 * |
|---|---|---|---|
| 기업 재무제표 | 10년 |
| |
| 분석가 컨센서스 추정치 | +3년 |
|
|
| 시장 가격 | 30년 |
| |
| 지분 구조 | 10년 |
| |
| 경영진 | 10년 |
| |
| 주요 개발 | 10년 |
|
* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.
별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.
분석 모델 및 스노우플레이크
이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.
Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.
산업 및 섹터 지표
산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.
분석가 소스
3D Systems Corporation는 26명의 분석가가 다루고 있습니다. 이 중 4명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
| 분석가 | 기관 |
|---|---|
| Benjamin Reitzes | Barclays |
| Kenneth Vallace | Berenberg |
| Wamsi Mohan | BofA Global Research |